Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial Academic Article
Overview
authors
- Boorjian, Stephen A
- Alemozaffar, Mehrdad
- Konety, Badrinath R
- Shore, Neal D
- Gomella, Leonard G
- Kamat, Ashish M
- Bivalacqua, Trinity J
- Montgomery, Jeffrey S
- Lerner, Seth P
- Busby, Joseph E
- Poch, Michael
- Crispen, Paul L
- Steinberg, Gary D
- Schuckman, Anne K
- Downs, Tracy M
- Svatek, Robert S
- Mashni, Joseph
- Lane, Brian R
- Guzzo, Thomas J
- Bratslavsky, Gennady
- Karsh, Lawrence, MD, FACS, CPI
- Woods, Michael E
- Brown, Gordon
- Canter, Daniel
- Luchey, Adam
- Lotan, Yair
- Krupski, Tracey
- Inman, Brant A
- Williams, Michael B
- Cookson, Michael S
- Keegan, Kirk A
- Andriole, Gerald L
- Sankin, Alexander I
- Boyd, Alan
- O'Donnell, Michael A
- Sawutz, David
- Philipson, Richard
- Coll, Ruth
- Narayan, Vikram M
- Treasure, F Peter
- Yla-Herttuala, Seppo
- Parker, Nigel R
- Dinney, Colin P N
Publication Date
- 2021
published in
- LANCET ONCOLOGY Journal
Identity
Digital Object Identifier (DOI)
Additional Document Info
number of pages
- 10
start page
- 107
end page
- 117
volume
- 22
issue
- 1